“Real-World Patient Perspectives on Glipizide and Empagliflozin for Type 2 Diabetes: Glipizide Vs Empagliflozin”, J Diabesity, vol. 1, no. 1, p. 9, Oct. 2025, doi: 10.66381/jod.2025.005.